Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pru p 3-specific CD4+ T-cell receptors are the primary mediators of the cellular immune response to Pru p 3, the major allergen in peach (Prunus persica). These receptors, located on the surface of CD4+ T helper cells, recognize specific peptide fragments of the Pru p 3 protein presented by Major Histocompatibility Complex (MHC) class II molecules. In allergic individuals, the interaction between these TCRs and Pru p 3 epitopes typically triggers a Th2-biased immune response, leading to the production of allergen-specific IgE and subsequent allergic inflammation. Pru p 3 is a non-specific lipid transfer protein (nsLTP) known for its high stability and potential to cause severe systemic reactions, including anaphylaxis. Targeting these TCRs through allergen-specific immunotherapy (AIT) aims to induce immune tolerance by promoting the expansion of regulatory T cells or shifting the cytokine profile toward a Th1-type response. Understanding the specific TCR repertoire and the dominant epitopes, such as Pru p 3 11-25 and 57-71, is crucial for developing safer and more effective peptide-based vaccines for peach allergy.
Induction of peripheral T-cell tolerance, anergy, or immune deviation from a Th2-dominated response to a Th1 or regulatory T-cell (Treg) response through repeated exposure to specific Pru p 3 epitopes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pru p 3-specific CD4+ T-cell receptor (Pru p 3-specific TCR).